AB
HOWL icon

Amalgamated Bank’s Werewolf Therapeutics HOWL Stock Holding History

Amalgamated Bank’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,055
Closed -$1K – 3063
2025
Q1 		$1K Hold
1,055
– – ﹤0.01% 2913
2024
Q4 		$2K Hold
1,055
– – ﹤0.01% 2903
2024
Q3 		$2K Hold
1,055
– – ﹤0.01% 2934
2024
Q2 		$3K Buy
+1,055
New +$5.07K ﹤0.01% 2916
2022
Q2 		– Sell
-3,946
Closed -$17K – 3108
2022
Q1 		$17K Buy
+3,946
New +$27.6K ﹤0.01% 2848

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Amalgamated Bank's HOWL Position: Q2 2025 in Review

Amalgamated Bank sold out of Werewolf Therapeutics (HOWL) in Q2 2025, closing a stake of 1,055 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in HOWL in Q1 2022 and held it in 5 quarters. The position peaked at $17K in Q1 2022. 65 funds tracked by Wall St. Rank hold HOWL as of Q2 2025.

  • Amalgamated Bank reported no remaining Werewolf Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 1,055 Werewolf Therapeutics shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Werewolf Therapeutics in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's Werewolf Therapeutics position peaked at $17K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.